It is the race to control the global oral obesity drug market, oral GLP-1 adoption, triple agonist development, and the next generation of incretin therapies that could define a $150 billion metabolic health opportunity
If you are experiencing side effects during a dose escalation, stay on the low FDA-approved doses for a longer duration to avoid these side effects
If your pancreas cannot produce insulin at all (as in type 1 diabetes), GLP-1 medications will not help
Blurry or fluctuating vision Eye pain These are not just uncomfortable, temporary side effects
The brand describes it as personalized: the more detail you provide, the better the clinical team can assess whether treatment makes sense for you specifically
It works best when combined with a balanced diet, regular physical activity, and other healthy lifestyle habits